Skip to content

Free cash flow at other companies

Boston Scientific logo
Boston ScientificBSX
$171M-51.7%
AngioDynamics logo
AngioDynamicsANGO
-$4.13M+72.4%
Delcath Systems logo
Delcath SystemsDCTH
$287K-86.1%
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
-$1.16M-3,153%
LQD
Liquidia CorporationLQDA
$50.16M+262%
United Therapeutics logo
United TherapeuticsUTHR

Other financials

Income statement

See full
Revenue$8.9M-2.9%
Gross profit$7.7M0.0%
Operating income-$8.4M-14.8%
Net income$1.5M+115%
EPS (diluted)$0.03+108%

Balance sheet

See full
Cash & equivalents$56.6M+324%
Total debt$33.1M+4.4%
Total equity$12.8M+137%
Total assets$71.0M+148%

Cash flow

See full
Operating cash flow-$6.5M-44.0%
CapEx$141.0K-81.3%

Valuation

See full
Market cap$279.45M+45.1%
Enterprise value$255.97M+29.3%
P/S6.2×+0.9×

Profitability

See full
Gross margin85.1%-0.5pp
Operating margin-62.4%-16.8pp
Net margin-60.9%-13.4pp
FCF margin-45.2%-16.8pp

Returns & leverage

See full
Return on equity253.3%
Debt / equity2.6×
Current ratio5.8×+3.6×

Where this comes from

Calculated from TriSalus Life Sciences, Inc.’s reported figures.

The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about TriSalus Life Sciences, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TriSalus Life Sciences, Inc.'s free cash flow?
TriSalus Life Sciences, Inc. (TLSI) reported free cash flow of -$6.62M in Q1 2026.
How has TriSalus Life Sciences, Inc.'s free cash flow changed year-over-year?
TriSalus Life Sciences, Inc.'s free cash flow decreased by 26.0% year-over-year, from -$5.25M to -$6.62M.
What is the long-term trend for TriSalus Life Sciences, Inc.'s free cash flow?
Over 2 years (2023 to 2025), TriSalus Life Sciences, Inc.'s free cash flow has grown at a -39.2% compound annual growth rate (CAGR), from -$51.17M to -$18.93M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.